Xenetic Biosciences presents DNase I research on CAR T-cell resistance at ASH Annual Meeting

XBIO•2026-11-04

Xenetic Biosciences will present research on DNase I’s potential to reverse CAR T-cell resistance at the ASH Annual Meeting in New Orleans on December 12, 2026.

Xenetic Biosciences presents DNase I research on CAR T-cell resistance at ASH Annual Meeting

1. ASH presentation

Related News

Rigel announces Phase 1b R289 data presentation in lower-risk MDS at ASH

SoundHound AI expands Ultraviolette partnership to power electric vehicle voice co-pilot

Magic Empire Global secures $100 million credit facility from Anyu International

Voyager awarded $35M contract to manage NASA HUNCH

AMD shares rise as AI-driven data-center strength fuels growth outlook